GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » 22nd Century Group Inc (NAS:XXII) » Definitions » Debt-to-EBITDA

22nd Century Group (22nd Century Group) Debt-to-EBITDA : 0.06 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is 22nd Century Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

22nd Century Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $6.62 Mil. 22nd Century Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $9.76 Mil. 22nd Century Group's annualized EBITDA for the quarter that ended in Dec. 2023 was $255.25 Mil. 22nd Century Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.06.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for 22nd Century Group's Debt-to-EBITDA or its related term are showing as below:

XXII' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.41   Med: -0.06   Max: -0.03
Current: -0.41

During the past 13 years, the highest Debt-to-EBITDA Ratio of 22nd Century Group was -0.03. The lowest was -0.41. And the median was -0.06.

XXII's Debt-to-EBITDA is ranked worse than
100% of 33 companies
in the Tobacco Products industry
Industry Median: 1.64 vs XXII: -0.41

22nd Century Group Debt-to-EBITDA Historical Data

The historical data trend for 22nd Century Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

22nd Century Group Debt-to-EBITDA Chart

22nd Century Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -0.04 -0.08 -0.05 -0.41

22nd Century Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 -0.34 -0.37 -0.10 0.06

Competitive Comparison of 22nd Century Group's Debt-to-EBITDA

For the Tobacco subindustry, 22nd Century Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


22nd Century Group's Debt-to-EBITDA Distribution in the Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, 22nd Century Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where 22nd Century Group's Debt-to-EBITDA falls into.



22nd Century Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

22nd Century Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(6.622 + 9.756) / -40.414
=-0.41

22nd Century Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(6.622 + 9.756) / 255.248
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


22nd Century Group  (NAS:XXII) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


22nd Century Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of 22nd Century Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


22nd Century Group (22nd Century Group) Business Description

Traded in Other Exchanges
N/A
Address
500 Seneca Street, Suite 507, Buffalo, NY, USA, 14204
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has two operating segments; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain 95% less nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM, and The hemp/cannabis segment is engaged in providing hemp-derived cannabinoid ingredients and API, as well as a CDMO to the consumer goods industry. It derives a majority of its revenue from the tobacco segment.
Executives
Andrew Arno director C/O MERRIMAN CURHAN FORD GROUP, INC., 600 CALIFORNIA STREET, 9TH FLOOR, SAN FRANCISCO CA 94108
James A Mish director, officer: Chief Executive Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
John Franzino officer: Chief Administrative Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Peter Ferola officer: Chief Legal Officer BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
John J Miller officer: President, Tobacco 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Lucille S Salhany director C/O HEWLETT-PACKARD CO, 3000 HANOVER STREET, PALO ALTO CA 94304
Michael Zercher officer: Chief Operating Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Robert Hugh Kinsman officer: Chief Financial Officer 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Clifford B Fleet director 6601 WEST BROAD STREET, RICHMOND VA 23230
Richard F Fitzgerald officer: Chief Financial Officer C/O TECHPRECISION CORPORATION, ONE BELLA DRIVE, WESTMINSTER MA 01473
Anthony L. Johnson director C/O 22ND CENTURY GROUP, INC., 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Richard M. Sanders director 1119 PIEDRA RONDO, SANTA FE NM 87501
Roger D O'brien director C/O 22ND CENTURY GROUP, INC., 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Michael Koganov director 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Nora B Sullivan director C/O RAND CAPITAL CORP, 2200 RAND BLDG, BUFFALO NY 14203